Skip to content
HowShorted

Apellis Pharmaceuticals, Inc. short interest in 2026

In 2026, Apellis Pharmaceuticals, Inc.'s disclosed short interest ran from 14.31% of shares outstanding on 15 Jan 2026 to 8.40% on 30 Apr 2026, a change of -5.91 percentage points. The year's high was 19.86% on 31 Mar 2026 and its low 8.40% on 30 Apr 2026, averaging 15.80% across 8 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.12 days on 27 Feb 2026. Full history: Apellis Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Apellis Pharmaceuticals, Inc. in 2026

2026 in figures

Start of year
14.31% (15 Jan 2026)
End of year
8.40% (30 Apr 2026)
Change
-5.91 pp
High
19.86% (31 Mar 2026)
Low
8.40% (30 Apr 2026)
Average
15.80%
Highest days to cover
12.12 (27 Feb 2026)
SEC filings marked
3

Every report in 2026

Apellis Pharmaceuticals, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202614.31%5.26results (8-K)
30 Jan 202616.79%4.76
13 Feb 202619.51%11.26
27 Feb 202618.13%12.1210-K filed
13 Mar 202618.12%11.91
31 Mar 202619.86%2.64
15 Apr 202611.25%1.75
30 Apr 20268.40%3.06

See also: Apellis Pharmaceuticals, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.